Deeply cultivate anticholinergic and emergency drug raw materials

As a core manufacturer of anticholinergic and emergency APIs in China, Henan Purui Pharmaceutical Co., Ltd. has continuously strengthened its independent R&D and large-scale production in the field of specialty APIs in recent years. Relying on a modern production base covering approximately 120,000 square meters, the company has established a high-purity API synthesis production line that meets international standards. Its anticholinergic APIs (such as those used to treat chronic obstructive pulmonary disease and digestive system spasms) and emergency APIs (used in shock, poisoning, and other scenarios) have achieved stable exports, making it one of China's important API export bases.

Purui Pharmaceutical strictly adheres to national GMP quality management standards, equipped with precision testing instruments such as high-performance liquid chromatography and gas chromatography, implementing full-process quality control of APIs from synthesis, separation, purification to final products. Currently, the company's API products not only meet its own formulation production needs but are also widely used in the formulation development and commercial production of many well-known domestic and international pharmaceutical companies. Through continuous technological innovation, Pury Pharmaceutical has been approved to establish the "Henan Provincial Anticholinergic Engineering Technology Research Center," further promoting the industrialization of process optimization and green synthesis technologies for this type of API.

A company representative stated, "We will continue to focus on anticholinergic and emergency APIs as our core breakthroughs, enhance our global supply chain service capabilities, and expand into more specialty API products, striving to become a trusted API partner for global customers."